Mei Lin Chen-Lim, PhD, RN, CCRC, is Nurse Scientist, Center for Pediatric Nursing Research & Evidence-Based Practice, Children’s Hospital of Philadelphia, and Adjunct Assistant Professor, University of Pennsylvania, School of Nursing, Philadelphia, Pennsylvania.
Margaret A. McCabe, PhD, RN, FAAN, is Senior Director, Center for Pediatric Nursing Research & Evidence-Based Practice, Children’s Hospital of Philadelphia, and Adjunct Professor of Nursing, University of Pennsylvania, School of Nursing, Philadelphia, Pennsylvania
Haolin Xu, MS, is Biostatistician III, Duke Clinical Research Institute, Duke University, Durham, North Carolina.
Laine E. Thomas, PhD, is Associate Professor, Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.
Christopher B. Forrest, MD, PhD, is Professor of Pediatrics, Children’s Hospital of Philadelphia, Pennsylvania.
Shira Birnbaum, PhD, RN, is Associate Professor, School of Nursing, Rutgers University, Newark, New Jersey. At the time this research was completed, she was a Medical Writer, Center for Pediatric Nursing Research & Evidence-Based Practice, Children’s Hospital of Philadelphia, Pennsylvania.
Laura E. Webb, BS, CCRP, is Project Leader, HERO Registry, Duke Clinical Research Institute, Duke University, Durham, North Carolina.
Emily C. O’Brien, PhD, is Associate Professor, Department of Population Health Sciences, Duke University, Durham, North Carolina.
Accepted for publication May 6, 2022.
The study reported in this publication was conducted using the National Patient-Centered Clinical Research Network (PCORnet). PCORnet has been developed with funding from the Patient-Centered Outcomes Research Institute (PCORI).
The Nurse Healthcare Worker Exposure Response and Outcomes (HERO) Registry was funded by PCORI through PCORI Award (COVID-19-2020-001), “HERO Registry & Trial: Healthcare Worker Exposure Response and Outcomes.” The Independence Blue Cross Foundation Award funded the HERO Study, “The Nurse HERO Study: Evaluating the Impact of COVID-19 Pandemic on Nurses (Phase I).”
The authors would like to thank the participating healthcare workers contributing to the HERO Registry across the United States. The authors would also like to acknowledge the contributions of Eloise Flood, Nursing Librarian, for reviewing and editing the article and Walter Faig, Biostatistician, for providing biostatistical review support; both were from the Children’s Hospital of Philadelphia.
Drs. Thomas, O’Brien, and Forrest report grants from PCORI, during the conduct of the study. Dr. O’Brien also reports grant from Pfizer. The remaining authors have no conflicts of interest to report.
The HERO Registry study procedures were reviewed by the Duke University School of Medicine Institutional Review Board and approved by the Western Institutional Review Board (Pro00105284). The Nurse HERO Study was reviewed and determined as nonhuman subjects research by the Children’s Hospital of Philadelphia Institutional Review Board (#21-018739).
HERO Registry Study, COVID-19, ClinicalTrials.gov identifier NCT04342806; registered April 8, 2020; the date the first participant was enrolled April 13, 2020; https://clinicaltrials.gov/ct2/show/NCT04342806
Corresponding author: Mei Lin Chen-Lim, PhD, RN, CCRC, Children’s Hospital of Philadelphia, 3500 Civic Center Blvd., Philadelphia, PA 19104 (e-mail: [email protected]).
